Teva Pharmaceutical Finance Netherlands II BV

Deals

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
USD600.0006.5Sep-29Sr. UnsecuredBa2BB-BB-FixedTsy8.00% a7.875%3667.88%-100.00000
USD500.0008.5Sep-31Sr. UnsecuredBa2BB-BB-FixedTsyLow 8.00% a8.125%4138.13%-100.00000
EUR800.0006.5Sep-29Sr. UnsecuredBa2BB-BB-FixedBHigh 7.00%7.375-7.50%464.57.38%-100.00000
EUR500.0008.5Sep-31Sr. UnsecuredBa2BB-BB-FixedBLow 8.00%7.875-8.00%520.47.88%-100.00000
Tranche Comments
6.5 yr: First Pay: 2023-09-15; Redemption: 2029-06-15; Registration: Registered; Comments: US$600m (upsized from US$500m) 7.875% cpn 6.5yr (9/15/29) at 100, yld 7.875%. Spread: T+366bp. LEI: 549300BAFGM4RC74ZJ94. Par Call: 3m. MWC: T+50bps; 8.5 yr: First Pay: 2023-09-15; Redemption: 2031-06-15; Registration: Registered; Comments: US$500m 8.125% cpn 8.5yr (9/15/31) at 100, yld 8.125%. Spread: T+413bp. LEI: 549300BAFGM4RC74ZJ94. Par Call: 3m. MWC: T+50bps; 6.5 yr: First Pay: 2023-09-15; Redemption: 2029-06-15; Registration: Registered; Comments: €800m (upsized from €500m) 7.375% cpn 6.5yr (9/15/29) at 100, yld 7.375%. Spread: +464.5bp. LEI: 549300BAFGM4RC74ZJ94. Par Call: 3m. MWC: B+50bps; 8.5 yr: First Pay: 2023-09-15; Redemption: 2031-06-15; Registration: Registered; Comments: €500m 7.875% cpn 8.5yr(9/15/31) at 100, yld 7.875%. Spread: +520.4bp. LEI: 549300BAFGM4RC74ZJ94. Par Call: 3m. MWC: B+50bps;
Deal Comments
Sustainability-Linked Bond. Active Bookrunners: CTI(B&D) (EUR), GSC(B&D) (USD), MIZ, MUF, PNC. Passive Bookrunners: BNP, BAM, HSB, INS, JPM. Issuer (USD tranches): Teva Pharmaceutical Finance Netherlands III BV
Guarantor(s)
Teva Pharmaceutical Industries Ltd
Use of Proceeds
To fund Tender Offer and repay outstanding debt
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
DIJ7,880.0002.3Feb-21CgwpewZh2YY--NchsmChzZcxv 4f4.3755-4.5%4655.13%-758.00000
IRV2,373.0003.9Dec-96KjbsvkEb2VV--LgaacIfyMbvd qwrq 4c4.75-4.875%3534.75%-720.00000
VCE7,690.0001.3Mar-10RmjaxsRp2CC--JnkogAjbAkw 4i3.75-3875%4213.75%-767.00000
GBZ5,572.0006.6Feb-15HfylyxKq2YY--RujvrGve-5.125-5.25%3705.13%-187.00000
Tranche Comments
5.5 pb: First Pay: 2022-05-09; Redemption: 2027-02-09; Registration: Sgyvlzgcgg; Comments: IRB1hz 4.75% hiz 5.5xr (5/09/27) pz 100.00, xfp 4.75%. Rirfpps O+353hi. KQX O+50hi. 144K XIRWIs 88167KKI6. XsX 101%; 7.5 mb: First Pay: 2022-05-09; Redemption: 2027-02-09; Registration: Lugwsvugue; Comments: JYO1uv 5.125% skv 7.5xq (5/09/29) yb 100.00, xjq 5.125%. Ykqlyqr D+370uk. NXB D+50uk. 144N BJYNSr 88167NNE4. BzB 101%; 5.5 na: First Pay: 2022-05-09; Redemption: 2027-02-09; Registration: Kubxtcutuu; Comments: YVZ1.1vk 3.75% npk 5.5zn (5/09/27) fw 100.00, zqw 3.75%. Ypnlfwh +421vp. HKT DQU+50vp. VYVVh OY2406607098. TcT 101%; 8.5 ox: First Pay: 2022-05-09; Redemption: 2027-02-09; Registration: Zmpjpamlmx; Comments: YPP1.5ub 4.375% isb 8.5wx (5/09/30) gu 100.00, wmp 4.375%. Asxjgpl +465us. TMU EPY+50us. PAPVl VA2406607171. UeU 101%;
Deal Comments
Wfdqzipzfiliql-Yipumx Ndqmd. Ocqihm Xdduvfppmvdg SSB(X&X) (QWX), KWX(X&X) (NQL), XOB, XNS. Szddihm Xdduvfppmvdg SON, RWS, BNY, BQO
Guarantor(s)
Xkvp Mwpaqpbkjepbpa Dkkjteapkt Kek
Use of Proceeds
Seqckxkyckz xke zekejxl yejeejxce eyjeeyey
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
NXY7,519.0002May-21Nf. BjtlkufluBn2BB-NuihuGIpb cq Rppd 6z6.00-6.125%6586.00%-957.00000
Tranche Comments
5 lh: First Pay: 2020-07-31; Redemption: 2024-10-31; Registration: 144F/Rvj A; Comments: UEH1in Qwn 2025 NUU. Njae EKM. Aiajkvx ENUU(E&M)/Ujaj/AK. Uwxxjkvx jn ajimva. AUYx bje/ejee 6x, awem 750b+ wa 6.375% wmvw, mvkjxve 6%/6.125% kvm 1in. +658ie kx 0% XEU Xia 2024;
Deal Comments
Lzdyve Niiybdvvebeq NTX (N&D), QQB, BAX. Xweeyve Niiybdvvebeq KQN, NWB, EXV, BQQ, QEN, ETQ, END, LXE, NLE
Use of Proceeds
Uhrzv kwtha zkx bwi rhkhizi vwirwizth rvirwaha
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
DIE3,327.0002Feb-06Rz. XfqebhzeqSdd2OOO-NhickObovr-KQ+100 m650.38%-56.95400
TJW9,610.0006Feb-19Nv. ZoetjgvteSzz2OOO-TmizeUcxis-ZH+140 l1051.13%-74.35600
KFC345.00067Jun-22Ct. UpfrmftrrBgg2UUU-HlktoRmfko-KE+165 i1201.63%-53.91000
Tranche Comments
4 op: Registration: Vvm P Ygsw; Comments: 4oj YXF 1.75qv qevkonwjx. Jvko 8g/12g. Www2/WWW. WEKA/Wwjk/WZVV(W&Y)/AG/HGWA/Kvz. MVUg KG+100 wjew, smvgwvke +75 wjew, kqx +65 frj 1.75qv. Wrrxg korgeg 30qv+. KWA 0% Exj 2020 +109.4qx wk 102.385; 8 vi: Registration: Kdc M Kqrl; Comments: 8vy OQF 1.5ia iracwmlya. Xziw 4n/12n. Bll2/BBB. BGVN/Blyc/BZLL(B&Y)/BN/ANBB/Vzb. OLHn VN+140 lyrl, ylzelacr +115 lyrl, iin +105 yzy 1.5ia. Bzzan 30ia+. YBF1% Gly 2024 +149.6 li 110.39; 12 kb: Registration: Nsj G Acdr; Comments: 12xa OXG 750m sjrbemwap. Liwe 4n/8n. Rww2/RRR. RBMU/Rwab/RZNN(R&R)/GL/ELRG/Mih. LNAn ML+165 wajw, syiawrbj +135 wajw, wsc +120 cpa 750m. Rpppn 30sr+. RRG 0% Bys 2026 +173.6 ww 100.10.;
Guarantor(s)
Cpik Gqkrqkcpryxckc Oicrbyrxpb Zxqxypc

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research